The Society of Family Planning is relieved by the Supreme Court (SCOTUS) decision in United States Food and Drug Administration (FDA) v Alliance for Hippocratic Medicine (AHM). In a unanimous decision, the Court held that AHM, the plaintiffs, did not have standing. This means that the case will be sent back to the lower court to decide whether to dismiss the claims brought by AHM.


In pursuit of our vision of just and equitable abortion informed by science, the Society supports and uplifts research regarding the safety and efficacy of medication abortion.

Clinical guidance

To support clinicians who administer medication abortion, the Society provides evidence-informed and person-centered guidance. 


The Society supports ongoing learning about medication abortion for clinicians, scholars, and advocates.

Media/advocacy contact information

For media or partnership inquiries, contact Jenni Villavicencio, MD, MPP, Senior Director of Public Affairs and Advocacy at